Cryoport Intrinsic Value – Cryoport, experiences significant decrease in short interest during September

October 19, 2024

☀️Trending News

Cryoport ($NASDAQ:CYRX), Inc. is a leading provider of temperature-controlled logistics solutions for the life sciences industry, including biopharmaceuticals and clinical trials. The company offers a range of services, such as cold chain packaging, storage, and transportation, utilizing advanced cryogenic technology. This has made Cryoport a key player in the rapidly growing market for cold chain logistics, as the demand for temperature-sensitive products continues to rise. One of the notable developments for Cryoport in September was a significant decrease in short interest. Short interest refers to the number of shares that have been sold short by investors, anticipating a decline in stock price. This decrease indicates a positive sentiment towards Cryoport’s stock among investors.

Furthermore, Cryoport has been consistently expanding its global presence, with the acquisition of two European companies in September. These acquisitions have not only broadened the company’s reach but also strengthened its capabilities in providing end-to-end supply chain solutions for customers. In addition to these factors, Cryoport’s stock has been performing well in the market, with a steady increase in its share price over the past few months. This has likely led to some short sellers covering their positions, resulting in the decrease in short interest. With a promising outlook for the life sciences industry and Cryoport’s key position in this market, it would not be surprising to see further improvements in the company’s stock performance in the future.

Stock Price

This highlights a positive trend for the company, as it indicates a decrease in bearish sentiment among investors. On Friday, CRYOPORT‘s stock opened at $7.21 and closed at $7.55, representing a 5.89% increase from the previous day’s closing price of $7.13. This rise in stock price can be attributed to the decrease in short interest, which may have sparked buying activity among investors. Short interest refers to the number of shares that have been sold short by investors, meaning they are betting on the stock price to decrease. As short interest decreases, it indicates that fewer investors are expecting the stock price to go down.

This can be seen as a positive sign for Cryoport, Inc. and may signal a shift in sentiment towards the company’s future growth potential. It reflects growing confidence in the company’s performance and its ability to sustain its growth trajectory. As the company continues to deliver strong financial results and expand its market reach, it is likely that this trend will continue in the coming months. Live Quote…

About the Company

  • Cryoport_experiences_significant_decrease_in_short_interest_during_September”>Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Cryoport. More…

    Total Revenues Net Income Net Margin
    236.35 -54.63 -25.2%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Cryoport. More…

    Operations Investing Financing
    0.41 57.93 -28.98
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Cryoport. More…

    Total Assets Total Liabilities Book Value Per Share
    1k 463.13 10.98
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Cryoport are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    81.4% -16.0%
    FCF Margin ROE ROA
    -17.2% -4.4% -2.4%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – Cryoport Intrinsic Value

    As a research team at GoodWhale, we have conducted an analysis on the well-being of CRYOPORT, a leading provider of temperature-controlled supply chain solutions for the life sciences industry. Our findings suggest that the company is currently undervalued by a significant margin. After carefully examining the company’s financial performance and future prospects, we have determined that the intrinsic value of CRYOPORT’s share is around $35.1. This valuation has been calculated using our proprietary Valuation Line, which takes into account various factors such as revenue growth, profit margins, and industry trends. At the time of writing, CRYOPORT’s stock is trading at $7.55, representing a substantial undervaluation of 78.5%. This presents a compelling buying opportunity for investors who are looking to capitalize on the potential growth and success of the company. Our analysis suggests that CRYOPORT has a strong financial position and a promising future outlook. The company’s innovative solutions and services cater to a growing demand for temperature-controlled logistics in the life sciences sector. This trend is expected to continue in the coming years, providing CRYOPORT with ample opportunities for further growth and expansion. In conclusion, our research has shown that CRYOPORT is currently undervalued in the market, presenting an attractive investment opportunity. We believe that the company’s strong fundamentals and favorable industry trends make it a promising long-term investment for investors. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    In the logistics and transportation industry, there is intense competition among companies to provide the most efficient and cost-effective services. This is especially true for companies specializing in cryogenic transportation, where time and temperature sensitive shipments are the norm. In this arena, CryoPort Inc. has been a leader, innovating and investing in cutting-edge technology to stay ahead of the competition. Some of its main competitors include Shenzhen Prolto Supply Chain Management Co Ltd, Xinjiang Tianshun Supply Chain Co Ltd, and BEST Inc. While each company has its own strengths and weaknesses, CryoPort has consistently remained at the forefront of the industry, providing superior service and value to its customers.

    – Shenzhen Prolto Supply Chain Management Co Ltd ($SZSE:002769)

    Shenzhen Prolto Supply Chain Management Co Ltd has a market cap of 3.23B as of 2022, and a Return on Equity of 2.47%. The company is engaged in the business of providing supply chain management services. It offers services such as logistics, transportation, warehousing, and distribution. The company has a network of over 1,000 warehouses in China.

    – Xinjiang Tianshun Supply Chain Co Ltd ($SZSE:002800)

    Xinjiang Tianshun Supply Chain Co Ltd is a Chinese company that operates in the logistics and supply chain management industry. The company has a market capitalization of 2.2 billion US dollars as of 2022 and a return on equity of 6.85 percent. Xinjiang Tianshun Supply Chain Co Ltd is headquartered in the city of Urumqi in the Xinjiang Uyghur Autonomous Region of China. The company was founded in the year 2006.

    – BEST Inc ($NYSE:BEST)

    BEST Inc. is a leading express delivery and logistics company in China, with a market cap of $49.1 million as of 2022. The company has a return on equity of -60.92%. BEST Inc. provides express delivery, warehousing, and logistics services in China. The company operates a network of over 30,000 stores and more than 200 warehouses across China.

    Summary

    Investors should take note of the recent short interest decline for Cryoport, Inc. in September. This could suggest a bullish sentiment towards the stock, as short sellers are reducing their bets against it. Additionally, on the same day that the short interest declined, the stock price also increased, indicating potential positive momentum for the company. Investors may want to keep an eye on Cryoport as it could be a promising investment opportunity in the biotechnology sector.

    However, further research and analysis of the company’s financials and industry trends should be conducted before making any investment decisions.

    Recent Posts

    Leave a Comment